December 7-8, 2021| Virtual Event

Agenda – ALL TIMES ARE IN EASTERN TIME

Speakers will be available for Q&A and further dialogue within their respective ‘Meet The Speaker’ Break Out Roundtables: A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!

Robert Allen,
Lead, Worldwide Engagement & Channel Planning, U.S. Oncology
BRISTOL MYERS SQUIBB

Prodeep Bose
Executive Vice President, Growth and Innovation
THE BLOC
  • Learn how to partner with organizations and community leaders that have trust and faces to set up testing spaces
  • Connect and recruit physicians to set virtual education platforms to understand the importance of data
  • Understand the opportunities where there is lack of access to help drive and deploy a more permanent mobile medical strategy
  • Intersection of Corporate Social Responsibility and Health Equity and the power of story sharing
Iris Lundy
Director, Health Equity
SENTARA HEALTHCARE
  • Adopting clinical trial designs with HEOR to convey a medicine’s value story
  • Importance of applying DE&I across the industry in the development phase for clinical trials
  • Using a patient centric approach and further innovation to solve unmet needs for patients from R&D through commercialization
Melaina Boyce 
Head of In Country Study Operations, US, Canada, LATAM
EMD SERONO

Adit Mane
Senior Product Manager, Managed Care Marketing
GENENTECH
  • Discover how the knowledge of health disparities and social determinants of health will help to increase outreach to underserved communities
  • Explain the importance of health literacy and meeting patients where they are
  • Describe how cultural sensitivity awareness will impact the HCP–patient relationship and help prevent healthcare bias
  • Support patients by providing them with the tools to have improved confidence and better conversations with HCPs around health equity & increased access
Tracy Wilson
Field Medical Director
PFIZER

Allow for the movement into smaller groups of your industry peers based upon the respective topics, and aligning your shared interests/expertise. A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but also with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!


Meet The Speaker Roundtable For The 10:05 Session

Iris Lundy
Director, Health Equity
SENTARA HEALTHCARE
Meet The Speaker Roundtable For The 10:25 Session

Adit Mane
Senior Product Manager, Managed Care Marketing
GENENTECH

Melaina Boyce
Head of In Country Study Operations, US, Canada, LATAM
EMD SERONO
Meet The Speaker Roundtable For The 10:50 Session

Tracy Wilson
Field Medical Director
PFIZER
  • Importance of increasing diversity in clinical trials to reflect the population’s disease prevalence, especially in light of the changing demographics in the US
  • How do we ensure transparency and build trust to enable patients who are BIPOC to participate in trials
  • Strategies on infrastructure, training, support for sites and planning for the long term – with inclusion of multiple stakeholders
  • Cultural sensitivity and strategies to remove barriers for participation
Sara Nochur 
Chief Diversity, Equity and Inclusion Officer
ALNYLAM PHARMACEUTICALS

Janine Jansen
Senior Director of Inclusion & Diversity
TEVA PHARMACEUTICALS
Over the past year and a half - the world was impacted by social unrest incidents. Many companies have made health equity and the efforts around recruitment of clinical trial recruitment/engagement of the POC a business transformation which was an impactful way of transforming their commercial operations. In this panel panelists will discuss: 
  • Commitments companies claimed to get a sense of a pulse check within your company and as an industry
  • What more has to be done to move this forward
  • How do we work with people and the work we do in healthcare
  • What has worked? What hasn’t?
  • Ensuring diversity is recognized, supported, and implemented across the organization
  • Holistically analyze your WFH and paternity leave policies
  • Follow Allena pharmaceuticals descriptor of caring for both patient and employees
  • Extending leadership teams to ensure high level roles are diverse
Alicja Januszewicz
Vice President, People & Culture
ALLENA PHARMACEUTICALS

A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!


Meet The Speaker Roundtable For The 11:30 Session

Sara Nochur
Chief Diversity, Equity and Inclusion Officer
ALNYLAM PHARMACEUTICALS

Janine Jansen
Senior Director of Inclusion & Diversity
TEVA PHARMACEUTICALS
Meet The Speakers Roundtable For The 11:50 SessionMeet The Speaker Roundtable For The 12:50 Session

Alicja Januszewicz
Vice President, People & Culture
ALLENA PHARMACEUTICALS
In this session, award-winning health equity innovator Sylvie Leotin will offer a powerful new lens to address health disparities.  Drawing on insights from her personal cancer experience, exclusive qualitative research with Black patients, and decades of expertise in human-centered design, Sylvie will illuminate unrealized blind spots preventing organizations from delivering empathic, patient-centered care to marginalized patients.

Sylvie Leotin, 
Chief Executive Officer
EQUIFY HEALTH
  • Connecting SDoH with your organization’s broader goals and strategic initiatives
  • Operationalizing SDoH efforts across your life science organization so it becomes an integral component of the core business
  • Understanding alternative ways that Digital Health can help close (vs. broaden) the Health Equity Gap
Nicole Lowery
Director, Population Health Strategy Office of Health Affairs and Advocacy
HUMANA
  • Understand the framework used by companies in their approach to DE&I both internally and externally
  • Strategies for developing and sustaining DE&I initiatives across your companies and with your leadership
  • Explore goals and metrics to assess progress and make improvements
  • Discuss the strategies and tactics being deployed to increase diversity in clinical trials in the Life Science industry
Whitney Harvey, MHA
Director, Diversity, Equity, and Inclusion
PRIME THERAPEUTICS

Dana Middleton
Health Equity Advocacy and Integration Practitioner
BLUE CROSS BLUE SHIELD OF KANSAS CITY

Mikel Whittier
Director, Health Equity, Diversity & Inclusion
UNIVERSITY OF CALIFORNIA LOS ANGELES

Allow for the movement into smaller groups of your industry peers based upon the respective topics, and aligning your shared interests/expertise. A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but also with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!


Meet The Speaker Roundtable for 1:30 Session

Sylvie Leotin,
Chief Executive Officer
EQUIFY HEALTH
Meet The Speaker Roundtable for 1:50 SessionMeet The Speaker Roundtable for 2:10 Session

Whitney Harvey, MHA
Director, Diversity, Equity, and Inclusion
PRIME THERAPEUTICS

Dana Middleton
Health Equity Advocacy and Integration Practitioner
BLUE CROSS BLUE SHIELD OF KANSAS CITY

Mikel Whittier
Director, Health Equity, Diversity & Inclusion
UNIVERSITY OF CALIFORNIA LOS ANGELES

Speakers will be available for Q&A and further dialogue within their respective ‘Meet The Speaker’ Break Out Roundtables: A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!

  • Rationale for including social risk scores in analysis of key pharmaceutical metrics to better understand patient access to treatment
  • Correlation between social risk and key pharmaceutical metrics in hyperlipidemia and migraine treatment classes
  • Implications of incorporating social risk and race into key metrics for stakeholders across the healthcare community including payers, providers, and patients
Hank Kessler
Executive Director of Value and Access
AMGEN
  • Explore BMS’ mission to develop and deliver innovative medicines to help patients prevail over serious diseases
  • Increasing the ability to treat more patients by having a deeper understanding of who they are and the unique challenges they face
  • The importance of having patience trust your science - and how BMS can work towards this goal through building a diverse workforce
Alison Handler
Director, Health Equity and Partnerships
BRISTOL MYERS SQUIBB

Shamika Williams
Senior Director, Strategy and Marketing - HBCU Initiative • Worldwide Training and Talent Development
BRISTOL MYERS SQUIBB

Mark Chaballa, BS, PharmD
Medical Scientist, US Medical Immunology and Fibrosis
BRISTOL MYERS SQUIBB

Lorena Kuri
Director, Clinical Trial Diversity Strategy 
BRISTOL MYERS SQUIBB
  • Discuss how companies design their trials long term so it is most impactful
  • Infuse equity in more day to day activities so no patient is left behind
  • Emphasize and target specific populations with multichannel approaches

Allow for the movement into smaller groups of your industry peers based upon the respective topics, and aligning your shared interests/expertise. A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but also with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!


Meet The Speaker Roundtable for 10:00 Session

Hank Kessler
Executive Director of Value and Access
AMGEN
Meet The Speaker Roundtable for 10:25 Session

Alison Handler
Director, Health Equity & Partnerships
BRISTOL MYERS SQUIBB

Shamika Williams
Senior Director, Strategy and Marketing - HBCU Initiative • Worldwide Training and Talent Development
BRISTOL MYERS SQUIBB

Mark Chaballa, BS, PharmD
Medical Scientist, US Medical Immunology and Fibrosis
BRISTOL MYERS SQUIBB

Lorena Kuri
Director, Clinical Trial Diversity Strategy
BRISTOL MYERS SQUIBB
Meet The Speaker Roundtable for 11:25 Session
Innovation in digital therapeutics, targeted and personalized therapy, continuous monitoring, nano-tech health.
Or are we building a dark dystopian future ala Isaac Asimov or Yuval Ben Hariri?
The choice is ours to make.
Join us to look towards the light.

Prodeep Bose
Executive Vice President, Growth and Innovation
THE BLOC
  • Developing strategies to promote access to care among diverse patient populations
  • Understanding the important dynamics and nuances of the SDoH landscape
Parisa Sanandaji
Director, Patient Advocacy
INTERCEPT PHARMACEUTICALS
Robyn Carson
Vice President, Patient-Centered Outcomes Research
ABBVIE
Meet The Speaker Roundtable for 12:00 Session

Prodeep Bose
Executive Vice President, Growth and Innovation
THE BLOC
Meet The Speaker Roundtable for 12:25

Parisa Sanandaji
Director, Patient Advocacy
INTERCEPT PHARMACEUTICALS
Meet The Speaker Roundtable for 12:50

Robyn Carson
Vice President, Patient-Centered Outcomes Research
ABBVIE
  • Connecting with your organization’s broader health equity goals and strategic initiatives
  • Operationalizing health equity efforts across your life science organization so it becomes an integral component of the core business
  • Understanding the important dynamics and nuances of the SDoH landscape
  • Recognizing the importance of Data and Partnerships in advancing equity initiatives within your organization
  • Understanding thoughtful ways that Digital Health can contribute to diminishing (vs. broadening) systemic health disparities
Elizabeth Hermsen
Head, Global Antimicrobial Stewardship & Health Equity in Infectious Diseases
MERCK

Josette Gbemudu
Executive Director, Health Equity and Social Determinants of Health
MERCK
Stacy Ward Charlerie PharmD, MBA
Director Product Development
WALGREENS PRIME

Brian C Urban MS, MBA
Senior Manager, Product Innovation Development
WALGREENS PRIME
Meet The Speaker Roundtable for 1:25 Session

Elizabeth Hermsen
Head, Global Antimicrobial Stewardship & Health Equity in Infectious Diseases
MERCK

Josette Gbemudu
Scientific Strategy, Marketing, Anesthesia & Surgery Franchise Lead
MERCK
Meet The Speaker Roundtable for 1:45 Session

Stacy Ward Charlerie PharmD, MBA
Director Product Development
WALGREENS PRIME

Brian C Urban MS, MBA
Senior Manager, Product Innovation Development
WALGREENS PRIME
Robert Allen,
Lead, Worldwide Engagement & Channel Planning, U.S. Oncology
BRISTOL MYERS SQUIBB

Prodeep Bose
Executive Vice President, Growth and Innovation
THE BLOC